On Thursday, December 17th, 2020 the Virtual Life Sciences Investor Forum (VLSIF) presents a six biotech companies….
European Union
The United Nations Commission on Narcotic Drugs (CND) removed cannabis from its global narcotic drugs list, also known as the Single Convention on Narcotic Drugs, earlier this week. The…
Today’s federal election results could change the regulatory landscape in Oregon and Washington DC, as the residents of those states will vote to decide if psilocybin should be decriminalised….
Xphyto Therapeutics (XPHY.C) diagnostic partner, 3a-Diagnostics GmbH, is getting onboard with the latest rush to develop a COVID-19 diagnostic kit, using reverse transcription polymerase chain reaction (RT-PCR) technology, which…
Increased product efficacy and patient convenience is anticipated through faster onset of drug action, more predictable therapeutic activity and ease of use….
IM Cannabis (IMCC.C) announced its first shipment from its EU-GMP supply partner into Germany yesterday, as well as their three new distribution agreements penned by Adjupharm GmbH, it’s German…
Xphyto and 3a are developing rapid screening tests for COVID-19 and other high-risk pandemic threats, including H1N1 (swine flu) and H5N1 (avian flu), with a specific focus on early…
Xphyto’s test may be ideal to catch the super-spreaders – the infectious carriers blithely attending drumming circles because they feel healthy….
Eurolife Brands (EURO.C) has made some inroads into the German market lately, up a retail location in the city of Ingolstadt and an outdoor hemp facility near Dresden, Germany….
“Visual confirmation of test results (probe activation) was observed in five to seven minutes,” states Xphyto….